Member Info for Tenantry

Or from the same band

"I'll be the last to know "

To anyone looking here the current court ruling 17/6/26 in favour of the NGOs against the State may provide an opportunity for get some shares in this company (which has had its problems over the last year with regard to Ramp Up) at a price well below the last placing which was fully subscribed by all the major stakeholders.

DYOR,

Im invested and intend to stay invested as I believe the state will request that Nordic obtain a new Permit stating critcial mineral need. But and its a risk they may ask for a more expensive waste route of landfill!!!

:)

Saint, HFH, Jonnyr

I will retract the 1/2 - full terminology I appreciate your comments, My post was intended to highlight that cohort 1 had had their dose and that was it, The next cohort will get a different dose as approved by the DMSB.

My understanding of the trial is that The Cohort 1 patients will not receive any additional dosage as part of the trial and 141 is conflating issues by suggesting that they now move the next approved dose level.

I appreciate all the comments and perhaps the term "competent incompetent "is extremely apt with regard to my level of knowledge and as such as I should not try to communicate at the levels of some of the more competent contributors in this field and to this board.

Saint, I wont argue that the trials lowest dose was half and next level is full. But im sure cohort 1 are finished in the trial for any additional top ups.

Cohort 2 is approved to next level of trial doseage which I believe to be the designed optimum full dose.

Cheers and GLA

141, your twisting the words.

The trial proceeds to full dose stage for adults

p1 p2 and p3 have had half dose and that is it for them as for as the clinical trail goes.

Adult P4 and beyond gets full dose as the DSMB approved moving to next stage,

Child P1 get half dose .

Can someone other that 141 please advise if im wrong.

Regards

Still no word on the repair offering.

Kvinnerhead is still on radar and getting ready for exploratory drilling in 2026

:)

Brilliant, i did have a moment there JHFH.

Alls Ok now.

Roll on tomorrow....worried about the stockmarket overall with world events seemingly being driven along with no one at the steering wheel and a brick on the accelerator..

Good luck all.

JHFH, Is that shares or pounds?

LTL 84 ......Kingpin explains in his post.

I will await responses from people who may haveca clue as to what Vander is referring to.

Its Sunday and after Toon win against all forces deployed by FA to prevent victory I'm struggling to focus.

GLA

Well another Kick in the proverbials.

Can only hope this investment will allow loans to be repaid and provide sufficient funding till full production.

Repair offering for smaller share holders might soften the impact

Hope you are OK Mick

Thanks for that HFH... I like your thinking, probably a Xmas wish list from all all holders .

Cheers and ATB to all

"Test runs are all ok @ made 👍"

Where have you seen / heard this CheckRicky?

Notposting.

I knew your comment wasn't aimed at me....my response was an attempt at humour, sarcasm or something along those lines.

If anyone's responses on here are AI generated I recognise the risk , I also recognise FUD wrapped up as concern and contrary views.

I really was just having a laugh though.

Take care all.

Honestly Nitposting, I got the question out of my own lack of intelligence. Nothing artificial about it at all.

Haywain, thank you for that.

You should do a "Ladybird book of Medical Research " that explains it so well. :)

Haywain, I'm sorry of I phrased my question in a way which gave you the impression, I didn't understand that MDA are a research hospital, I get that and understand that HEMO pay for the clinical trials to be done and that recent placings and deals may have secured sufficient trials going forward.

I also understand that the physicians do research and that was where my query was really trying to gain and understanding of the question "who owns the data"

I think you are saying that MDA and by association Dr Short and others do use the product to conduct additional research ( I couldn't even hazard a guess as to how they determine how and what to research into) but if MDA can determine an additional route for expansion of capabilities with the product how does that data become the property of another party other than HEMO.? Or am I completely barking up the wrong tree here and getting hung up on "ownership" when what I really should be focussing on "is who discovered and owns the research" and by definition receives appropriate recognition in the field of oncology.

If MDA find an additional route / benefit in SOC for a product, as well as plaudits do they and their researchers achieve financial reward from that research as the owner of that data?

Finally, may I as a shareholder who stumbled across this share 6 years ago thank you for all the information and support you have provided on LSE and other BBs. and which has made holding this share easier for me by explaining the science and the processes that we have to follow to get HEMO to market.

Apologies if this seems a dumb question

If Hemo are only paying for one set of data but MDA are doing more tests and they own that data how and who benefits from that data.

Would MDA make suggestions to HEMO or others as to that data, possibly advise pharma companies as to other benefits or negative effects of HG-CT-01.

It seems such a strange concept to me that someone can have your product and be doing tests that you have requested they do but they could test for other things and own the data. Is this a mechanism for MDA to get a slice of a deal by testing at minimal cost to Hemo?

JHFH.

I think you have my email, could you let me have the details to join the WattsApp group.

Regards